Previous close | 58.35 |
Open | 58.35 |
Bid | 22.74 x 1000 |
Ask | 0.00 x 800 |
Day's range | 56.21 - 59.40 |
52-week range | 46.93 - 93.80 |
Volume | |
Avg. volume | 202,882 |
Market cap | 1.356B |
Beta (5Y monthly) | 1.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.37 |
Earnings date | 08 Mar 2022 - 14 Mar 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 93.20 |
Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) is possibly approaching a major achievement in its business, so we...
SANTA BARBARA, Calif., June 06, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 10:30 am Eastern Time.
Insiders who bought US$4.5m worth of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) stock in the last year have seen...